Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.20
1.81%
After-hours: Aug 15, 2025, 07:54 PM EDT

Coya Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-6.11B -17.14M -14.88M -10.7M -10.1M -10.3M -7.99M -12.36M -12.96M -13.28M -12.24M -10.77M -8.08M -5.63M -4.89M -3.26M -1.93M -966.07K
Depreciation & Amortization
6.86M 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 27.36K 32.98K 30.17K 27.36K 30.71K 20.78K 18.46K 16.13K 5.95K 3.42K 1.71K
Stock-Based Compensation
2.12B 1.08B 2.66M 2.11M 1.6M 1.13M 872.25K 705.68K 512.76K 366.31K 207.35K 162.55K 105.37K 157.68K 233.22K 206.59K 193.94K 96.97K
Other Working Capital
1.02M -1.56M -6.1M -8.98M -7.71M -5.15M -3.63M -299.55K -78.4K 116.95K -93.45K 1.07M 315.25K 134.95K 74K 2.23K -2.48K -1.24K
Other Non-Cash Items
-4.63B -3.9B 25K -6.86K -126.8K -506.44K -67.27K 1.48M 3.13M 4.48M 3.65M 1.69M 165.66K -735.56K -295.28K 161.44K 147.6K 73.8K
Deferred Income Tax
n/a n/a n/a 225.05K 344.99K 1.07M 610.45K 385.4K 265.46K -464.18K n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
878.39K -1.46M 1.88M -1.78M 1.38M 3.4M -4.64M -1.4M -1.53M -255.88K 751.84K 2.03M 1.22M 272.2K 577.73K 2.23K -2.48K -1.24K
Operating Cash Flow
-8.61B -2.84B -10.29M -10.12M -6.87M -5.18M -11.19M -11.17M -10.55M -9.12M -7.24M -6.03M -5.74M -5.09M -3.9M -2.89M -1.59M -794.84K
Capital Expenditures
-25K -25.01K -50.01K -50K -25K -25K n/a n/a n/a n/a n/a n/a -85.83K -111.31K -136.8K -136.8K -50.98K -25.49K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-25K -25K -25K -168.18K -193.18K -543.19K -543.19K -740K -875K -525K -525K -135K n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -25K -218.19K -218.19K -568.19K -543.19K -740K -875K -525K -525K -135K -85.83K -111.31K -136.8K -136.8K -50.98K -25.49K
Debt Repayment
n/a n/a n/a n/a n/a -14.25M n/a n/a n/a 24.72M 10.47M 10.47M 10.47M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
19.75M 19.9M 780.67K 239.2K 239.2K 14.34M 89.95K -104.07K -113.88K -15.3M -1.11M -1.35M -1.34M -406.31K -340.58K 1K 1K 500.00
Financial Cash Flow
28.77M 33.92M 16.03M 30.51M 30.57M 25.42M 38.43M 14.15M 14.14M 23.67M 9.36M 9.12M 9.13M -406.31K -340.58K 1K 1K 500.00
Net Cash Flow
-8.58B -2.81B 5.71M 20.17M 23.47M 19.67M 26.69M 2.24M 2.72M 14.03M 1.59M 2.95M 3.31M -5.61M -4.38M -3.02M -1.64M -819.82K
Free Cash Flow
-8.61B -2.84B -10.31M -10.15M -6.9M -5.2M -11.19M -11.17M -10.55M -9.12M -7.24M -6.03M -5.82M -5.2M -4.04M -3.02M -1.64M -820.32K